Biocon Biologics
Karan Cariappa has a diverse professional background ranging from working in procurement and strategic programs in the pharmaceutical industry to managing ground fleet and transportation in the logistics sector. With an MBA in Operations Strategy, Karan's experience includes roles at companies such as Biocon Biologics, AstraZeneca, and McKinsey & Company. At Biocon Biologics, Karan currently serves as the Head of Strategic Programs - Emerging Markets, where Karan coordinates strategic projects globally.
This person is not in any teams
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics